• LAST PRICE
    0.5040
  • TODAY'S CHANGE (%)
    Trending Up0.0140 (2.8571%)
  • Bid / Lots
    0.4819/ 14
  • Ask / Lots
    0.5050/ 14
  • Open / Previous Close
    0.5010 / 0.4900
  • Day Range
    Low 0.4810
    High 0.5200
  • 52 Week Range
    Low 0.3400
    High 4.5000
  • Volume
    232,347
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.49
TimeVolumeAGLE
09:32 ET9480.52
09:44 ET48160.516739
09:46 ET42830.52
09:51 ET42000.52
09:55 ET1000.5149
09:57 ET24200.4901
10:02 ET402000.51
10:06 ET2000.51
10:09 ET5000.509899
10:11 ET2000.51
10:18 ET2000.4902
10:22 ET2000.5
10:26 ET1750.505
10:36 ET3000.505
10:49 ET39000.505
10:56 ET1000.505
10:58 ET23000.5002
11:00 ET9510.5013
11:05 ET2500.5002
11:07 ET6000.5025
11:14 ET10000.5023
11:21 ET1000.505
11:25 ET1000.505
11:45 ET199010.5003
11:48 ET3000.505
11:50 ET20000.5002
11:52 ET7010.5003
11:57 ET1000.505
12:03 ET41000.505
12:10 ET1000.505
12:12 ET1880.504208
12:15 ET114000.5005
12:21 ET2000.5004
12:24 ET6000.503
12:28 ET12000.505
12:32 ET1000.50305
12:35 ET11000.50305
12:37 ET17000.505
12:39 ET3970.5049
12:44 ET4740.50305
12:48 ET9900.505
12:51 ET1000.50305
12:55 ET503650.49
12:57 ET1000.4955
01:06 ET1000.4954
01:08 ET1100.4953
01:11 ET1000.4954
01:13 ET5000.4954
01:20 ET1000.4954
01:29 ET10000.5
01:33 ET4000.4999
01:38 ET9000.4998
01:40 ET2000.4977
01:45 ET1230.499078
01:47 ET1000.4997
01:49 ET8000.481
01:51 ET15000.5
01:58 ET3000.5
02:25 ET10000.4949
02:32 ET1120.498942
02:38 ET1000.4999
02:54 ET3000.49
02:56 ET1000.4998
03:08 ET5000.4998
03:14 ET285180.5
03:19 ET2000.5025
03:21 ET1000.5006
03:35 ET26710.5099
03:37 ET8180.504
03:42 ET36410.507
03:44 ET24630.505
03:46 ET7080.505
03:48 ET2020.505
03:51 ET2000.5049
03:53 ET11000.5046
03:55 ET20000.5046
03:57 ET11000.5055
04:00 ET58250.504
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAGLE
Aeglea Bio Therapeutics Inc
31.0M
-0.4x
---
United StatesFNCH
Finch Therapeutics Group Inc
24.7M
-0.2x
---
United StatesOBSV
Obseva SA
22.1M
-0.2x
---
United StatesLABP
Landos Biopharma Inc
16.5M
-0.3x
---
United StatesCDAK
Codiak BioSciences, Inc.
29.7M
-1.2x
---
United StatesEMMA
Emmaus Life Sciences Inc
18.8M
-1.1x
---
As of 2023-02-04

Company Information

Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology company. It is focused on human enzyme therapeutics to treat people with rare metabolic diseases. Its lead product candidate is pegzilarginase, which is a recombinant human arginase 1 that enzymatically degrades the amino acid arginine to lower arginine levels in patients with Arginase 1 Deficiency. It has engineered pegzilarginase with modifications that enhance the stability and arginine-degrading activity of the enzyme in human plasma. Its second product candidate, AGLE-177, is a novel PEGylated ( polyethylene glycol) human enzyme engineered to degrade free homocysteine and homocystine in patients with Homocystinuria. The Company is evaluating Pegzilarginase in a global pivotal Phase III pivotal PEACE (Pegzilarginase Effect on Arginase one Deficiency Clinical Endpoints) trial and Phase I/II open-label extension trial. It is also conducting a Phase I/II clinical trial for the treatment of patients with Homocystinuria.

Contact Information

Headquarters
805 Las Cimas Parkway, Suite 100AUSTIN, TX, United States 78746
Phone
512-942-2935
Fax
512-872-5121

Executives

Independent Chairman of the board
Russell Cox
President, Chief Executive Officer, Director
Jeffrey Goldberg
Chief Financial Officer
Jonathan Alspaugh
General Counsel, Company Secretary
Jim Kastenmayer
Chief Commercial Officer, Chief Business Officer
Michael Hanley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$31.0M
Revenue (TTM)
$5.8M
Shares Outstanding
61.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.69
EPS
$-1.15
Book Value
$1.70
P/E Ratio
-0.4x
Price/Sales (TTM)
5.3
Price/Cash Flow (TTM)
---
Operating Margin
-1,482.53%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.